Today we bring the trial to the patient. We design trials that seamlessly mesh with patients’ day-to-day activities and capture important trial information while reducing the burden on both patients and investigators.
COSTA PANAGOS, President,
Research & Development Solutions
Technology advancements are allowing data collection in new and less obtrusive ways to the patient. Combined with decentralized models and advanced patient engagement tools, patient-centric drug development is now a reality.
Assess your protocol against real world evidence using advanced analytics, and reduce the risk of costly amendments.
Leverage a global network of Phase I clinical pharmacology units to build diversity in patient populations and access a range of geographic regions for early clinical development (ECD) programs.
Improve the performance of your clinical trials with the power of the IQVIA CORE.
Identify the best performing sites for your trial in less time with new machine learning and predictive modeling methods.
Predict enrollment more accurately and increase the number of patients per site using data-driven patient recruitment solutions.